Related references
Note: Only part of the references are listed.Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF
Ken-ichi Fujita et al.
MOLECULAR CANCER (2007)
Production of Wnt inhibitors by myeloma cells: Potential effects on canonical Wnt pathway in the bone microenvironment
Nicola Giuliani et al.
CANCER RESEARCH (2007)
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton
Roland Baron et al.
ENDOCRINOLOGY (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma
Deborah J. Heath et al.
CANCER RESEARCH (2007)
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation
Marianna C. Politou et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass
Frederic Morvan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
GJ Spencer et al.
JOURNAL OF CELL SCIENCE (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3
LM Galli et al.
DEVELOPMENTAL DYNAMICS (2006)
A versatile tool for conditional gene expression and knockdown
J Szulc et al.
NATURE METHODS (2006)
Downregulation of Wnt signaling by increased expression of Dickkopf-1 and-2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells
G van der Horst et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Wnts induce migration and invasion of rnyeloma plasma cells
YW Qiang et al.
BLOOD (2005)
Pathogenesis of myeloma bone disease
GD Roodman
BLOOD CELLS MOLECULES AND DISEASES (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Soluble receptor activator of nuclear factor κB ligand-osteoprotegerin ratio predicts survival in multiple myeloma:: proposal for a novel prognostic index
E Terpos et al.
BLOOD (2003)
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow
CA Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
Wnt signaling in B-cell neoplasia
YW Qiang et al.
ONCOGENE (2003)
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
BY Mao et al.
NATURE (2002)
Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk
YW Qiang et al.
BLOOD (2002)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity
S Yaccoby et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
RD Little et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
N Giuliani et al.
BLOOD (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease
C Seidel et al.
BLOOD (2001)
Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
RN Pearse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
A Bafico et al.
NATURE CELL BIOLOGY (2001)
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins
BY Mao et al.
NATURE (2001)
Share Paper
